Lanean...

Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma

INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Lymphoma Myeloma Leuk
Egile Nagusiak: Mian, Hira, Fiala, Mark, Wildes, Tanya M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/
https://ncbi.nlm.nih.gov/pubmed/31843543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!